APA (7th ed.) Citation

AC, C., AP, K., JU, B., JK, R., KM, A., X, G., . . . PA, N. (2025). Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants. Research square. https://doi.org/10.21203/rs.3.rs-6271510/v1

Chicago Style (17th ed.) Citation

AC, Conley, et al. "Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's Disease: A Single Ascending-Dose Study in Healthy Participants." Research Square 2025. https://doi.org/10.21203/rs.3.rs-6271510/v1.

MLA (9th ed.) Citation

AC, Conley, et al. "Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's Disease: A Single Ascending-Dose Study in Healthy Participants." Research Square, 2025, https://doi.org/10.21203/rs.3.rs-6271510/v1.